We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$104B
AUM Growth
+$8.72B
(+9.1%)
Cap. Flow
-$256M
Cap. Flow
% of AUM
-0.25%
Top 10 Holdings %
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$35.4M |
| 2 |
P
Everpure Inc
P
|
+$21M |
| 3 |
NVIDIA
NVDA
|
+$20.7M |
| 4 |
American Homes 4 Rent
AMH
|
+$19.3M |
| 5 |
DAY
Dayforce
DAY
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$46.7M |
| 2 |
Apple
AAPL
|
+$41.8M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$32.3M |
| 4 |
Gilead Sciences
GILD
|
+$27.8M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$25.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.42% |
| 2 | Financials | 13.09% |
| 3 | Healthcare | 11.94% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LENZ
3176
LENZ Therapeutics
LENZ
$168M
| $103K | ﹤0.01% |
4,598
+141
| +3% | +$2.93K |
|
3177
Smartbird Inc
BIRD
$22.3M
| $103K | ﹤0.01% |
7,385
+186
| +3% | +$3.47K |
|
3178
Atara Biotherapeutics
ATRA
$76.1M
| $102K | ﹤0.01% |
5,903
+86
| +1% | +$1.53K |
|
3179
AlTi Global
ALTI
$493M
| $101K | ﹤0.01% |
17,896
+1,126
| +7% | +$6.95K |
|
3180
Noodles & Co
NDLS
$107M
| $101K | ﹤0.01% |
6,629
-58
| -0.9% | -$1.13K |
|
3181
Prelude Therapeutics
PRLD
$390M
| $100K | ﹤0.01% |
21,166
+763
| +4% | +$2.97K |
|
3182
Duluth Holdings
DLTH
$159M
| $100K | ﹤0.01% |
20,451
+727
| +4% | +$3.55K |
|
|
KPN
3183
DELISTED
ROYAL KPN NV ADS (EA REPTG 1 ORD SH)
KPN
| $99.8K | ﹤0.01% |
26,911
+7,646
| +40% | +$28.4K |
|
|
KZR
3184
DELISTED
Kezar Life Sciences
KZR
| $98.7K | ﹤0.01% |
10,944
+258
| +2% | +$2.35K |
|
3185
Mammoth Energy Services
TUSK
$163M
| $97.1K | ﹤0.01% |
26,681
+506
| +2% | +$1.91K |
|
3186
NLI Holdings
NL
$317M
| $97K | ﹤0.01% |
13,238
-3,716
| -22% | -$20.9K |
|
3187
Protalix BioTherapeutics
PLX
$198M
| $96.3K | ﹤0.01% |
76,455
+2,769
| +4% | +$4.13K |
|
3188
XPeng
XPEV
$11.6B
| $96.3K | ﹤0.01% |
12,540
+3,455
| +38% | +$33.5K |
|
3189
Kaltura
KLTR
$267M
| $96.1K | ﹤0.01% |
71,185
+3,156
| +5% | +$4.9K |
|
3190
ESS Tech
GWH
$18.9M
| $96K | ﹤0.01% |
8,855
+336
| +4% | +$4.58K |
|
3191
LivePerson
LPSN
$32.3M
| $95.5K | ﹤0.01% |
6,387
-44
| -0.7% | -$1.51K |
|
3192
iShares MSCI Denmark ETF
EDEN
$206M
| $93K | ﹤0.01% |
761
| – | – |
|
|
SWKH
3193
DELISTED
SWK Holdings
SWKH
| $92.8K | ﹤0.01% |
6,720
+168
| +3% | +$2.26K |
|
3194
Vesta Real Estate
VTMX
$3.18B
| $91.8K | ﹤0.01% |
2,340
| – | – |
|
|
EGRX
3195
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $89.9K | ﹤0.01% |
17,166
-175
| -1% | -$960 |
|
3196
PrimeEnergy Resources
PNRG
$298M
| $89.7K | ﹤0.01% |
895
+109
| +14% | +$10.8K |
|
3197
Ramaco Resources Class B
METCB
$408M
| $88.2K | ﹤0.01% |
7,578
+173
| +2% | +$1.99K |
|
|
ORGN
3198
DELISTED
Origin Materials
ORGN
| $86.8K | ﹤0.01% |
5,675
+134
| +2% | +$2.33K |
|
|
BWAY
3199
Brainsway
BWAY
$622M
| $86.7K | ﹤0.01% |
32,764
+20,514
| +167% | +$64K |
|
3200
Ispire Technology
ISPR
$98.2M
| $86.5K | ﹤0.01% |
14,110
+1,121
| +9% | +$11.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2024 Portfolio in Review
As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3%. RhumbLine Advisers opened 62 new positions and exited 71, leaving the 4,372-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
- RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
- RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
- RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
- RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
- RhumbLine Advisers opened 62 new positions and closed 71 in Q1 2024.
- RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.
Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.